This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

REGISTER BY FEBRUARY 10 FOR EARLY EVENT PLATFORM ACCESS

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
February 27 - March 2, 2023 | Part of BPI West
San Diego Convention CenterSan Diego, CA

Nikolaus Trede, MD, PhD
Vice President of Early Clinical Development at Century Therapeutics

Profile

Nick Trede is the VP of Early Clinical Development at Century Therapeutics, a fully integrated biotechnology company developing transformational next generation iPSC-derived cell therapies for hematological malignancies and solid tumors. Nick joined Century in 2021 after 5 years of cell therapy experience with Juno, Celgene and BMS. He holds an MD from Freiburg University, a PhD in immunology from Universite Paris VII, trained in Pediatrics and Pediatric Heme/Onc at Boston Children’s Hospital and DFCI. Nick did his postdoctoral research modeling zebrafish immune-mediated diseases in the HHMI lab of Leonard Zon and continued this work in his University of Utah lab before moving to industry in 2013.

Agenda Sessions

  • ELiPSE-1: FIH trial of CNTY-101, an allo-evasion equipped CAR-iNK product for CD19 positive NHL

    10:30am